Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics

Yu-kun Li, Juan Zou, Dong-mei Ye, Ying Zeng, Chang-ye Chen, Gui-fang Luo, Xi Zeng

Open source

DOI
10.1016/j.lfs.2019.117113
Published
2020-01
Container
Life Sciences
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lfs.2019.117113,
  title = {Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics},
  author = {Yu-kun Li and Juan Zou and Dong-mei Ye and Ying Zeng and Chang-ye Chen and Gui-fang Luo and Xi Zeng},
  year = {2020},
  journal = {Life Sciences},
  doi = {10.1016/j.lfs.2019.117113},
  url = {https://doi.org/10.1016/j.lfs.2019.117113}
}

RIS

TY  - JOUR
TI  - Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics
AU  - Yu-kun Li
AU  - Juan Zou
AU  - Dong-mei Ye
AU  - Ying Zeng
AU  - Chang-ye Chen
AU  - Gui-fang Luo
AU  - Xi Zeng
PY  - 2020
JO  - Life Sciences
DO  - 10.1016/j.lfs.2019.117113
UR  - https://doi.org/10.1016/j.lfs.2019.117113
ER  - 

APA

Li, Y., Zou, J., Ye, D., Zeng, Y., Chen, C., Luo, G., & Zeng, X. (2020). Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics. Life Sciences. https://doi.org/10.1016/j.lfs.2019.117113

Source records